Joint Venture Market Leader Novartis Consumer Health, a joint venture market leader in over-the-counter medicines, has a strong global presence in more than 30 countries, presenting significant sales opportunities for expansion and growth.
Recent Strategic Partnerships Recent partnerships with Clarius Mobile Health Corp and Volar Air Mobility indicate Novartis Pharma AG's commitment to innovation and collaboration, opening doors for sales opportunities in new markets and healthcare solutions.
Large Investments from Wealth Management Firms Substantial investments by companies like Granite Bay Wealth Management, Cobblestone Capital Advisors, and Financial Design Group reflect confidence in Novartis Pharma AG's financial health, signaling potential opportunities for high-value sales engagements.
Tech Integration and Digital Transformation With a tech stack including Glassbox, Blockchain, and SAP Information Steward, Novartis Consumer Health embraces technology for operational efficiency, paving the way for sales opportunities in the digital transformation and tech solution sectors.
Strategic Acquisitions and Collaborations Acquiring assets like those from Leqvio and forming partnerships with companies like Clarius Mobile Health Corp demonstrate Novartis Pharma AG's strategic growth approach, presenting potential sales opportunities through expanded product portfolios and market reach.
Novartis Consumer Health uses 8 technology products and services including Glassbox, Blockchain, CloudBees, and more. Explore Novartis Consumer Health's tech stack below.
| Novartis Consumer Health Email Formats | Percentage |
| First.Last@novartis.com | 91% |
| F.Last@novartis.com | 4% |
| FLast@novartis.com | 4% |
| First.L@novartis.com | 1% |
ManufacturingNew Jersey, United States1001-5000 Employees
Novartis and GSK have combined our Consumer Healthcare businesses to create a new joint venture Consumer Healthcare company. This new business is now a market leader in more than 30 countries as well as being the number one company worldwide for over-the-counter medicines. Some of our key brands now include: Sensodyne, Voltaren, Theraflu, Panadol, Otrivin, Horlicks, Zovirax & Abreva.
Company Overview
Media & News
Funding & FinancialsNovartis Consumer Health has raised a total of $2.4B of funding over 3 rounds. Their latest funding round was raised on Sep 16, 2020 in the amount of $2.1B.
Funding & FinancialsNovartis Consumer Health has raised a total of $2.4B of funding over 3 rounds. Their latest funding round was raised on Sep 16, 2020 in the amount of $2.1B.
1-888-653-2347 
support@leadiq.com